InTrack Investment Management Inc Purchases 750 Shares of Danaher Corporation $DHR

InTrack Investment Management Inc boosted its position in shares of Danaher Corporation (NYSE:DHR) by 8.7% in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 9,334 shares of the conglomerate’s stock after buying an additional 750 shares during the period. Danaher makes up about 1.2% of InTrack Investment Management Inc’s portfolio, making the stock its 29th biggest holding. InTrack Investment Management Inc’s holdings in Danaher were worth $1,844,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Notis McConarty Edward boosted its stake in Danaher by 3.0% during the second quarter. Notis McConarty Edward now owns 22,925 shares of the conglomerate’s stock valued at $4,529,000 after buying an additional 671 shares during the last quarter. Maryland State Retirement & Pension System raised its position in Danaher by 2.7% during the second quarter. Maryland State Retirement & Pension System now owns 31,009 shares of the conglomerate’s stock valued at $6,126,000 after purchasing an additional 823 shares during the period. Optas LLC raised its position in Danaher by 69.6% during the second quarter. Optas LLC now owns 2,892 shares of the conglomerate’s stock valued at $571,000 after purchasing an additional 1,187 shares during the period. Dempze Nancy E raised its position in Danaher by 5.9% during the second quarter. Dempze Nancy E now owns 20,762 shares of the conglomerate’s stock valued at $4,101,000 after purchasing an additional 1,149 shares during the period. Finally, Bar Harbor Wealth Management raised its position in Danaher by 1.5% during the second quarter. Bar Harbor Wealth Management now owns 26,555 shares of the conglomerate’s stock valued at $5,246,000 after purchasing an additional 385 shares during the period. 79.05% of the stock is owned by institutional investors.

Danaher Trading Down 1.7%

DHR opened at $205.13 on Thursday. The stock’s fifty day moving average is $200.41 and its two-hundred day moving average is $197.38. The company has a market capitalization of $146.88 billion, a P/E ratio of 43.64, a PEG ratio of 2.97 and a beta of 0.77. Danaher Corporation has a 52 week low of $171.00 and a 52 week high of $279.41. The company has a quick ratio of 1.22, a current ratio of 1.62 and a debt-to-equity ratio of 0.32.

Danaher (NYSE:DHR) last released its quarterly earnings data on Tuesday, July 22nd. The conglomerate reported $1.80 EPS for the quarter, topping the consensus estimate of $1.64 by $0.16. The company had revenue of $5.94 billion for the quarter, compared to the consensus estimate of $5.83 billion. Danaher had a return on equity of 10.70% and a net margin of 14.21%.Danaher’s quarterly revenue was up 3.4% on a year-over-year basis. During the same period last year, the business posted $1.72 EPS. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. Analysts forecast that Danaher Corporation will post 7.63 earnings per share for the current year.

Danaher Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, October 31st. Shareholders of record on Friday, September 26th will be issued a dividend of $0.32 per share. This represents a $1.28 annualized dividend and a yield of 0.6%. The ex-dividend date is Friday, September 26th. Danaher’s dividend payout ratio (DPR) is presently 27.23%.

Analyst Ratings Changes

A number of equities research analysts have issued reports on the company. Wall Street Zen upgraded Danaher from a “hold” rating to a “buy” rating in a research report on Friday, June 27th. UBS Group decreased their price objective on Danaher from $240.00 to $225.00 and set a “buy” rating on the stock in a research report on Wednesday, July 23rd. Barclays restated an “overweight” rating and set a $225.00 price objective (up from $215.00) on shares of Danaher in a research report on Tuesday, June 24th. Guggenheim restated a “buy” rating and set a $250.00 price objective on shares of Danaher in a research report on Wednesday, July 23rd. Finally, Evercore ISI increased their price target on Danaher from $226.00 to $245.00 and gave the stock an “outperform” rating in a report on Tuesday. Seventeen equities research analysts have rated the stock with a Buy rating and five have issued a Hold rating to the company’s stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $244.60.

Insider Buying and Selling

In other Danaher news, Director Teri List sold 2,778 shares of the firm’s stock in a transaction on Friday, August 22nd. The stock was sold at an average price of $211.06, for a total transaction of $586,324.68. Following the transaction, the director directly owned 20,751 shares in the company, valued at $4,379,706.06. This trade represents a 11.81% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. 11.10% of the stock is owned by insiders.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.